- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.41 Å
- Oligo State
- monomer
- Ligands
- 1 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 4 x SO4: SULFATE ION(Non-functional Binders)
- 2 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 17 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.6: 8 residues within 4Å:- Chain A: G.265, L.268, A.269, H.274, V.276, R.277, L.278, Y.304
Ligand excluded by PLIPEDO.7: 11 residues within 4Å:- Chain A: R.285, V.310, H.311, W.312, D.315, L.324, A.338, S.366, N.370, V.375, W.378
Ligand excluded by PLIPEDO.8: 6 residues within 4Å:- Chain A: R.285, P.319, A.320, K.321, T.369, Y.373
Ligand excluded by PLIPEDO.10: 8 residues within 4Å:- Chain A: E.235, S.237, A.238, L.241, Y.244, D.283, Q.284
- Ligands: EDO.11
Ligand excluded by PLIPEDO.11: 9 residues within 4Å:- Chain A: E.235, Y.244, F.246, Q.284, Y.313, S.345, N.396
- Ligands: EDO.10, NF8.17
Ligand excluded by PLIPEDO.12: 12 residues within 4Å:- Chain A: R.2, C.23, D.24, S.25, F.26, L.103, K.106, S.107, S.110, E.112, G.113, K.413
Ligand excluded by PLIPEDO.13: 6 residues within 4Å:- Chain A: P.3, C.4, G.46, R.47, R.48, E.50
Ligand excluded by PLIPEDO.14: 3 residues within 4Å:- Chain A: R.44, S.45, Y.487
Ligand excluded by PLIPEDO.15: 2 residues within 4Å:- Chain A: E.254, R.257
Ligand excluded by PLIPEDO.16: 4 residues within 4Å:- Chain A: R.277, K.303, V.305, H.306
Ligand excluded by PLIPEDO.18: 9 residues within 4Å:- Chain A: R.39, E.41, R.47, S.52, T.482, I.483, P.485, H.490, Y.492
Ligand excluded by PLIPEDO.19: 5 residues within 4Å:- Chain A: F.9, L.354, P.387, D.405, Y.412
Ligand excluded by PLIPEDO.20: 4 residues within 4Å:- Chain A: F.347, W.348, E.349, Q.350
Ligand excluded by PLIPEDO.21: 6 residues within 4Å:- Chain A: N.192, G.193, G.243, Y.244, P.245
- Ligands: SO4.5
Ligand excluded by PLIPEDO.22: 7 residues within 4Å:- Chain A: L.165, V.172, S.173, L.174, K.224, L.225, Q.226
Ligand excluded by PLIPEDO.23: 3 residues within 4Å:- Chain A: N.102, K.106, L.167
Ligand excluded by PLIPEDO.24: 5 residues within 4Å:- Chain A: R.2, T.21, Y.22, C.23, L.103
Ligand excluded by PLIP- 1 x NF8: (2~{R},3~{S},4~{S},5~{S})-5-fluoranyl-2-(hydroxymethyl)oxane-3,4-diol(Covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Rowland, R.J. et al., A baculoviral system for the production of human beta-glucocerebrosidase enables atomic resolution analysis. Acta Crystallogr D Struct Biol (2020)
- Release Date
- 2020-06-10
- Peptides
- Glucosylceramidase: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
BBB
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.41 Å
- Oligo State
- monomer
- Ligands
- 1 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 4 x SO4: SULFATE ION(Non-functional Binders)
- 2 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 17 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 1 x NF8: (2~{R},3~{S},4~{S},5~{S})-5-fluoranyl-2-(hydroxymethyl)oxane-3,4-diol(Covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Rowland, R.J. et al., A baculoviral system for the production of human beta-glucocerebrosidase enables atomic resolution analysis. Acta Crystallogr D Struct Biol (2020)
- Release Date
- 2020-06-10
- Peptides
- Glucosylceramidase: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
BBB